Creative Biolabs-Immuno-oncology

Anti-CD5 (clone Q-2E0Z) SynExpress pU-BF-I10-E Modified CD8+ T cells (CAT#: ITS-1224-CR1676)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CD5 (clone Q-2E0Z). We employs the pAS (pUC-BFP-IL-10-EcoRI) vector components and the SynExpress system of the lncRNA Base Editing/Positive feedback for a robust and sustained response against cancers.
Host
Humanized
Target
CD5
Clone
Q-2E0Z
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
BFP
Promoter
pUC
Effector Gene
IL-10
Insertion Sites
EcoRI
Gene Modification
Base Editing
Modification Domain
lncRNA
Carrier Type
pAS
Transformation Accuracy
0.94
Cell Culture
3D Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving